Sign Up

Sign up to our social GMP Questions and Answers Engine to ask and answer questions, and connect with other professionals.

Have an account? Sign In
or use


Have an account? Sign In Now

Sign In

Login to our social GMP Questions and Answers Engine to ask and answer questions and connect with other professionals.

Sign Up Here
or use

Forgot Password?

Don't have account, Sign Up Here

Forgot Password

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.


Have an account? Sign In Now
You must login to ask question.

or use

Forgot Password?

Need An Account, Sign Up Here
Qualistery – GMP Knowledge Provider Logo Qualistery – GMP Knowledge Provider Logo
Sign InSign Up

Qualistery – GMP Knowledge Provider

Qualistery – GMP Knowledge Provider Navigation

  • Home
  • GMP Learning
    • Live GMP Webinars
    • Webinar Recordings
  • Resources
    • Articles
    • Podcast
  • Speaking & Sponsorship
    • Speaking Partners (Organization)
    • Event Sponsorship
    • Speaking and Training Opportunities For GxP Experts
  • Contact
  • My Account
Search
Ask A Question

Mobile menu

Close
Ask a Question
  • Home
  • GMP Learning
    • Live GMP Webinars
    • Webinar Recordings
  • Resources
    • Articles
    • Podcast
  • Speaking & Sponsorship
    • Speaking Partners (Organization)
    • Event Sponsorship
    • Speaking and Training Opportunities For GxP Experts
  • Contact
  • My Account

Manufacturing

Share
  • Facebook
0Followers
18Answers
11Questions
Home/Manufacturing
Adv

Qualistery – GMP Knowledge Provider Latest Questions

Qualistery
  • 0
QualisteryLevel 2
Asked: September 17, 2021In: Manufacturing, Quality Assurance

How many containers of each component from each shipment must a firm sample and test to comply with the CGMP requirements for identity testing? Do the CGMPs permit the identity test on a pooled, or composite, sample of multiple containers?

  • 0

  • 2 2 Answers
  • 234 Views
Answer
Qualistery
  • 0
QualisteryLevel 2
Asked: September 15, 2021In: Manufacturing, Quality Assurance

What are the Specs and Requirements for conducting visual inspection as per Q&A 7?

  • 0

  • 1 1 Answer
  • 155 Views
Answer
Qualistery
  • 0
QualisteryLevel 2
Asked: September 13, 2021In: Commercial, Manufacturing

Is analytical testing required at product changeover, on equipment in shared facilities, following completion of cleaning validation?

  • 0

  • 1 1 Answer
  • 110 Views
Answer
Adv
Qualistery
  • 0
QualisteryLevel 2
Asked: September 12, 2021In: Commercial, Manufacturing

Does FDA require or recommend any special precautions or controls over the manufacturing of animal-derived drug ingredients to prevent contamination?

  • 0

  • 1 1 Answer
  • 75 Views
Answer
Qualistery
  • 0
QualisteryLevel 2
Asked: September 11, 2021In: Manufacturing

What are FDA’s primary concerns about pathogenic agent contamination of animal-derived drug ingredients?

  • 0

  • 1 1 Answer
  • 72 Views
Answer
Qualistery
  • 0
QualisteryLevel 2
Asked: September 9, 2021In: Manufacturing

What manufacturing contamination risks are presented by the different pathogenic agents?

  • 0

  • 2 2 Answers
  • 136 Views
Answer
Qualistery
  • 0
QualisteryLevel 2
Asked: September 6, 2021In: Manufacturing

How should manufacturers use the HBELs (Health-Based Exposure Limits)?

  • 0

  • 1 1 Answer
  • 50 Views
Answer
Qualistery
  • 0
QualisteryLevel 2
Asked: September 5, 2021In: Manufacturing

What are some ways to minimize pathogenic agent contamination in incoming animal-derived raw material?

  • 0

pathogenicraw material
  • 1 1 Answer
  • 62 Views
Answer
Qualistery
  • 0
QualisteryLevel 2
Asked: September 4, 2021In: Manufacturing

Are there control measures for minimizing pathogenic agent contamination in animal-derived drug ingredient manufacturing facilities?

  • 0

manufacturingpathogenic
  • 1 1 Answer
  • 61 Views
Answer
Anonymous
  • 0
Anonymous
Asked: August 13, 2021In: Manufacturing

Are (HBELs) Health-Based Exposure Limits required for all medicinal products?

  • 0

Are (HBELs) Health-Based Exposure Limits required for all medicinal products?

HBELshealth based exposure limitmedicinalproducts
  • 2 2 Answers
  • 103 Views
Answer
Load More Questions
Adv

Sidebar

Ask A Question

Stats

  • Questions 103
  • Answers 117
  • Best Answer 1
  • Users 71
  • Popular
  • Answers
  • Anonymous

    tablet hardness

    • 5 Answers
  • Qualistery

    What is Data Governance?

    • 3 Answers
  • Qualistery

    What is data life cycle?

    • 2 Answers
  • Md.Mahamudul Hossain Robin
    Md.Mahamudul Hossain Robin added an answer It is Completely depends on the design . There is… December 7, 2022 at 4:53 am
  • Yan Kugel
    Yan Kugel added an answer Dear Nadia, a recall is an action which the manufacturer… October 8, 2021 at 5:20 pm
  • Marc García Gómez
    Marc García Gómez added an answer Pharmaceutical manufacturers must demonstrate that bacterial, fungal, and yeast contamination… October 3, 2021 at 12:31 pm

Top Members

Yan Kugel

Yan Kugel

  • 0 Questions
  • 88 Points
Level 2
Qualistery

Qualistery

  • 85 Questions
  • 78 Points
Level 2
Shashi Ravi Suman Rudrangi, RPh

Shashi Ravi Suman Rudrangi, RPh

  • 0 Questions
  • 33 Points
Level 1

Trending Tags

Active Pharmaceutical Ingredient Airlock ALCOA+ analytical api APIs archiving A true copy audit trail Authorized Person Batch Batch Records Batch Recovery batch reworking Bracketing Calibration capa CGMP Change Control Clean Area cleaning cold chain monitoring Confirmation Testing Consignment contact lens solution Contamination Control Strategy Corrective Action Cross Contamination Data Governance data life cycle Delivery Design Space document retention schedule Drug Master File effectiveness electronic signature finished Pharmaceutical Product flexible intravenous glass GMP gmp&iso 9001 Good Manufacturing Practices good practices (GxP) hbel HBELs healthbased exposure limit health based exposure limit in-process control (IPC) In Process Control InterCompany Transfer Intermediate Product lamellae Large Volume Parenterals manufacturers manufacturing Marketing Authorization medical device medicinal metadata Operational Qualification Packaging Packaging Material pathogenic Performance Qualification Pharmaceutical manufacturers Pharmaceutical Manufacturing Pharmaceutical Product Pharmaceutical Production Pharmacopeia pq PQR process validation Product products QA QC Qualification Quality Assurance Quality Control Quality Planning quality policy quality risk management (QRM) Quality Unit Quarantine question raw material Reconciliation Reprocessing Sampling Self Contained Area single product solution bags sop special Specification Standard Operating Procedure starting material supplier qualifications supplier quality suppliers technology transfer usp Validation validation batches Validation batches in a Technology transfer Validation Master Plan validation report vp vr

Explore

  • Home
  • Add group
  • Groups page
  • Communities
  • Questions
    • New Questions
    • Trending Questions
    • Must read Questions
    • Hot Questions
  • Polls
  • Tags
  • Badges

Footer

Qualistery - GMP Knowledge Provider

Qualistery is a GMP knowledge database, and a social Questions & Answers engine which will help you dominate the arena.

Company

  • About Us
  • Contact Us

Legal

  • Impressum – Legal Disclosure
  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
  • Disclaimer

Services

  • GMP Online Education

GMP Resources

  • Articles
  • Podcast

Follow

© 2022 Qualistery. All Rights Reserved